Thu, December 5, 2024

[ Thu, Dec 05th 2024 ]: Thomas Matters

Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?

[ Thu, Dec 05th 2024 ]: Thomas Matters

Fed Leans Toward A December Interest Rate Cut

[ Thu, Dec 05th 2024 ]: Thomas Matters

Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today

[ Thu, Dec 05th 2024 ]: Thomas Matters

I would listen to Warren Buffett's advice and buy undervalued ASX shares today

[ Thu, Dec 05th 2024 ]: Thomas Matters

3 Top Buffett Stocks to Buy and Hold for the Long Haul

[ Thu, Dec 05th 2024 ]: Thomas Matters

Salesforce price target raised to $425 from $415 at Barclays

[ Thu, Dec 05th 2024 ]: Thomas Matters

Stellantis Is Headed for Disaster

[ Thu, Dec 05th 2024 ]: Thomas Matters

Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now.

[ Thu, Dec 05th 2024 ]: Thomas Matters

The CRA is Watching TFSA Holders: Here Are Some Red Flags to Avoid

[ Thu, Dec 05th 2024 ]: Thomas Matters

The UK tech stocks worth owning

[ Thu, Dec 05th 2024 ]: Thomas Matters

Google's new gen AI video model Veo available on Vertex AI private preview

[ Thu, Dec 05th 2024 ]: Thomas Matters

3 ASX 300 shares with ex-dividend dates before the end of 2024

[ Thu, Dec 05th 2024 ]: Thomas Matters

2 high-yield ASX dividend shares for Australian retirees

[ Thu, Dec 05th 2024 ]: Thomas Matters

5 things to watch on the ASX 200 on Thursday

[ Thu, Dec 05th 2024 ]: Thomas Matters

Dow Jones Futures: Bitcoin Hits $100,000; Nvidia Ready To Run?

[ Thu, Dec 05th 2024 ]: Thomas Matters

Here's Why Dave Inc. (DAVE) is a Great Momentum Stock to Buy

[ Thu, Dec 05th 2024 ]: Thomas Matters

Tony Robbins: These 3 Investments Can Make You Rich

[ Thu, Dec 05th 2024 ]: Thomas Matters

CMC Invest launches a flexible Isa - here's how i .. mes the latest platform to offer tax-free account

[ Thu, Dec 05th 2024 ]: Thomas Matters

News Highlights: Top Company News of the Day - Thursday at 1 AM ET

[ Thu, Dec 05th 2024 ]: MSN

Here are the top 10 ASX 200 shares today

[ Thu, Dec 05th 2024 ]: The Motley Fool

Why Intuitive Machines Stock Just Crashed 14%

[ Thu, Dec 05th 2024 ]: The Motley Fool

Why C3.ai Stock Soared 51% in November

[ Thu, Dec 05th 2024 ]: The Daily Telegraph

In 1964, we recommended five shares - we'd buy these again today

[ Thu, Dec 05th 2024 ]: Seeking Alpha

The Cost Of Euphoria: Why Palantir's Rally Could Be A Mirage

[ Thu, Dec 05th 2024 ]: Motley Fool Australia

1 Australian energy stock to buy confidently and 1 to avoid for now

[ Thu, Dec 05th 2024 ]: Thomas Matters

Best mid cap mutual funds to invest in December 2024

[ Thu, Dec 05th 2024 ]: Thomas Matters

Top Australian financial stocks to buy now
Wed, December 4, 2024

[ Wed, Dec 04th 2024 ]: Thomas Matters

Triumph Financial Stock Breakout: Why It's Just the Beginning

[ Wed, Dec 04th 2024 ]: Thomas Matters

Best Penny Stocks Right Now

[ Wed, Dec 04th 2024 ]: Thomas Matters

American Express (AXP) Returned +17.1% in Q3

[ Wed, Dec 04th 2024 ]: Thomas Matters

Suze Orman shared with Americans the best way to .. rpedo' - here's how to dodge it and retire richer

[ Wed, Dec 04th 2024 ]: Thomas Matters

Is easyJet's share price set to soar after strong 2024 results and upbeat business projections?

[ Wed, Dec 04th 2024 ]: Thomas Matters

Stock market today: Tech stocks and AI pull Wall Street toward more records

[ Wed, Dec 04th 2024 ]: Thomas Matters

Money blog: HMRC issues tax clarification - as Vi .. to start sharing seller information with tax man

[ Wed, Dec 04th 2024 ]: Thomas Matters

Dow Jones Today: Stock Futures Rise as Investors Digest Tech Earnings, Await Fed Chair Comments

[ Wed, Dec 04th 2024 ]: Thomas Matters

Stock market today: Wall Street points higher as earnings trickle in ahead of Friday's jobs report

[ Wed, Dec 04th 2024 ]: Thomas Matters

Stocks and bonds haven't moved together like this .. t's putting portfolios at risk, says State Street

[ Wed, Dec 04th 2024 ]: Thomas Matters

Canadian ETF Comparison Series: ZWK vs. CALL.B

[ Wed, Dec 04th 2024 ]: Thomas Matters

Best Stock to Buy Right Now: Amazon vs. Shopify

[ Wed, Dec 04th 2024 ]: Thomas Matters

Cathie Wood buys $22.1 million of battered tech stock

[ Wed, Dec 04th 2024 ]: Thomas Matters

UnitedHealth Projects Strong Financial Outlook for 2025

[ Wed, Dec 04th 2024 ]: Thomas Matters

Institutional investors optimistic about 2025 amid ongoing wars, China-U.S. tensions

[ Wed, Dec 04th 2024 ]: Thomas Matters

Can AI Boost These Growth Stocks Higher?

[ Wed, Dec 04th 2024 ]: Thomas Matters

Rating the Magnificent 7 Stocks in 2024

[ Wed, Dec 04th 2024 ]: Thomas Matters

Why Pure Storage Stock Is Sailing Higher After Earnings

[ Wed, Dec 04th 2024 ]: Thomas Matters

Should You Really Buy Stocks Before the New Year? Here's What History Says.

[ Wed, Dec 04th 2024 ]: Thomas Matters

Columbia Convertible Securities Fund Q3 2024 Commentary

[ Wed, Dec 04th 2024 ]: Thomas Matters

Can Rolls-Royce shares continue to outperform in 2025?

Why Janux Therapeutics Crushed the Market Today

News of an analyst's price-target hike plus a new round of capital-raising were the sparks that ignited Janux Therapeutics ( JANX 11.65%) stock on Wednesday. The clinical-stage biotech's share price ended the day nearly 12% higher, and this was on a very good day for the exchange with the S&P 500 rising by 0.6%.
Janux Therapeutics (NASDAQ: JANX) experienced a significant surge in its stock price on December 4, 2024, after the company announced positive interim data from its ongoing Phase 1 clinical trial for JANX007, a novel T-cell engager aimed at treating prostate cancer. The trial results indicated a favorable safety profile and promising early signs of efficacy, with several patients showing reductions in PSA levels and tumor size. This news led to a 45% increase in Janux Therapeutics' stock value, far outpacing the broader market's performance. The positive data has heightened investor confidence in the company's pipeline, particularly in its ability to develop effective cancer treatments, thereby driving the stock's impressive performance for the day.

Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/04/why-janux-therapeutics-crushed-the-market-today/ ]